Umbilical-cord blood cell transplantation conditioned with a reduced intensity-regimen is a practical salvage therapy for severe aplastic anemia refractory to immunosuppressive therapy with antithymocyte globulin/ciclosporin

Journal of Nippon Medical School

Volumn 74, Issue 6, 2007, Pages 424-429

  Tajika, Kenji ^a   Mizuki, Taro ^a   Nakayama, Kazutaka ^a   Yamaguchi, Hiroki ^a   Dan, Kazuo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Cord blood transplantation; Reduced intensity conditioning; Severe aplastic anemia

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; APLASTIC ANEMIA; ARTICLE; CASE REPORT; CELL LINEAGE; CONTINUOUS INFUSION; CORD BLOOD STEM CELL TRANSPLANTATION; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DONOR; FEMALE; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; RADIATION DOSE; REDUCED INTENSITY CONDITIONING; TREATMENT OUTCOME; WHOLE BODY RADIATION;

EID: 37349091436     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.74.424     Document Type: Article

References (19)

1. Brodsky RA, Jones RJ: Aplastic anaemia. Lancet 2005; 365: 1647-1656.
2. Davies JK, Guinan EC: An update on the management of severe idiopathic aplastic anaemia in children. Br J Haematol 2007; 136: 549-564
3. Bacigalupo A, Bruno B, Saracco P, et al.: Antilymphocyte globulin, cyclosporine, prednisolone and granulocyte colony-stimulating factor for sever aplastic anemia: an update of the GITMO/EBMT study on 100 patients. Blood 2000; 95: 1931-1934.
4. Locatelli F, Bruno B, Zecca M, et al.: Cyclosporin A and short-term methotrexate versus cyclosporine A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial. Blood 2000; 96: 1690-1697.
5. Ades L, Mary JY, Robin M, et al.: Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood 2004; 103: 2490-2497.
6. Kahl C, Leisenring W, Deeg HJ, et al.: Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up. Br J Haematol 2005; 130: 745-751.
7. Kojima S, Matsuyama T, Kato S, et al.: Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood 2002; 100: 799-803.
8. Deeg HJ, O'Donnell M, Tolar J, et al.: Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood 2006; 108: 1485-1491.
9. Margolis AD, Casper JT: Alternative-donor hematopoietic stem-cell transplantation for severe aplastic anemia. Semin Hematol 2000; 37: 43-55.
10. Srinvasan R, Takahashi Y, McCoy JP, et al.: Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation. Br J Haematol 2006; 133: 305-314
11. Kang HJ, Shin HY, Choi HS, Ahn HS: Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severer aplastic anemia. Bone Marrow Transplant 2004; 34: 939-943.
12. Bacigalupo A, Locatelli F, Lanino E, et al.: Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia; a report from the EBMT-SAA Working Party. Bone Marrow Transplant 2005; 36: 947-950.
13. Resnick IB, Aker M, Shapira MY, et al.: Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimen. Br J Haematol 2006; 133: 649-654.
14. Gupta V, Ball SE, Sage D, et al.: Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. Bone Marrow Transplant 2005; 35: 467-471.
15. Mao P, Wang S, Wang S, et al.: Umbilical cord blood transplant for adult patients with severe aplastic anemia using anti-lymphocyte globulin and cyclophosphamide and conditioning therapy. Bone marrow transplant 2004; 33: 33-38.
16. Mao P, Zhu X, Wang H, et al.: Sustained and stable hematopoietic deonor-recipient mixed chimerism after unrelated cord blood transplantation for adult patients with severe aplastic anemia. Eur J Haematol 2005; 75: 430-435.
17. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE: Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood 2003; 102: 1915-1919.
18. Lim SH, Zhang Y, Wang Z, et al.: Umbilical cord blood transplant in hepatitis C-associated severe aplastic anemia. Bone Marrow Transplant 2004; 33: 565-567.
19. Kusumi E, Miyakoshi S, Murashige N, et al.: Successful reduced-intensity stem cell transplantation (RIST) with mismatched cord blood in a 70-year-old patient with severe aplastic anemia (SAA). Bone Marrow Transplant 2003; 32: 1111-1112.